Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TXG
#1441
10x Genomics, Inc. Class A Common Stock
23.050
0
+15.37%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+15.37%
Aylık değişim
+6.71%
6 aylık değişim
+66.79%
Yıllık değişim
+66.79%
Önceki kapanış
19.980
0
Open
23.050
0
Bid
Ask
Low
23.050
0
High
23.050
0
Hacim
221
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
TXG
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Haberler
Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
Priceline, Carvana, DoorDash and more set to report earnings Wednesday
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Canaccord Genuity, 10X Genomics için hedef fiyatını 20 dolardan 22 dolara yükseltti
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity
Applied Materials and Rivian among market cap stock movers on Friday
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates
10X Genomics yeni fiyatlandırma stratejisi ile kazanç testine hazırlanıyor
10X Genomics faces earnings test as new pricing strategy debuts
Canada stocks higher at close of trade; S&P/TSX Composite up 0.71%